BACKGROUND: Biliopancreatic diversion (BPD) is a form of bariatric surgery that produces substantial and sustained weight loss, improved co-morbidities, and a higher quality of life. However, it does have associated sequelae such as vitamin D deficiency. With limited published data, a comprehensive review of vitamin D levels in BPD patients was warranted. METHODS: All available 25-hydroxyvitamin D (25-OH-D) levels were assessed from 219 BPD patients. The dates of 25-OH-D levels were compared to each individual patent's surgery date. Data was analyzed according to patient sex, ethnicity, age, and time from surgery. RESULTS: The majority (72.3%) of 25-OH-D levels (n = 607) in BPD patients were insufficient (</=30 ng/ml), and 46.8% were deficient (</=20 ng/ml). Statistical analysis revealed that 25-OH-D levels decrease over time with BPD patients (n = 0.0468), and no significant relationship exists with patient sex, ethnicity, or age. CONCLUSIONS: This study gives evidence that vitamin D deficiency and insufficiency is prevalent in BPD patients. Despite excess weight loss and oral vitamin D supplementation, the data shows that vitamin D levels continue to decrease over time in BPD patients. Since the current method of vitamin D supplementation is not producing ideal results, other protocol needs to be developed.
BACKGROUND: Biliopancreatic diversion (BPD) is a form of bariatric surgery that produces substantial and sustained weight loss, improved co-morbidities, and a higher quality of life. However, it does have associated sequelae such as vitamin D deficiency. With limited published data, a comprehensive review of vitamin D levels in BPD patients was warranted. METHODS: All available 25-hydroxyvitamin D (25-OH-D) levels were assessed from 219 BPD patients. The dates of 25-OH-D levels were compared to each individual patent's surgery date. Data was analyzed according to patient sex, ethnicity, age, and time from surgery. RESULTS: The majority (72.3%) of 25-OH-D levels (n = 607) in BPD patients were insufficient (</=30 ng/ml), and 46.8% were deficient (</=20 ng/ml). Statistical analysis revealed that 25-OH-D levels decrease over time with BPD patients (n = 0.0468), and no significant relationship exists with patient sex, ethnicity, or age. CONCLUSIONS: This study gives evidence that vitamin Ddeficiency and insufficiency is prevalent in BPD patients. Despite excess weight loss and oral vitamin D supplementation, the data shows that vitamin D levels continue to decrease over time in BPD patients. Since the current method of vitamin D supplementation is not producing ideal results, other protocol needs to be developed.
Authors: Melinda A Maggard; Lisa R Shugarman; Marika Suttorp; Margaret Maglione; Harvey J Sugerman; Harvey J Sugarman; Edward H Livingston; Ninh T Nguyen; Zhaoping Li; Walter A Mojica; Lara Hilton; Shannon Rhodes; Sally C Morton; Paul G Shekelle Journal: Ann Intern Med Date: 2005-04-05 Impact factor: 25.391
Authors: N Scopinaro; G F Adami; G M Marinari; E Gianetta; E Traverso; D Friedman; G Camerini; G Baschieri; A Simonelli Journal: World J Surg Date: 1998-09 Impact factor: 3.352
Authors: Erlend T Aasheim; Sofia Björkman; Torgeir T Søvik; My Engström; Susanna E Hanvold; Tom Mala; Torsten Olbers; Thomas Bøhmer Journal: Am J Clin Nutr Date: 2009-05-13 Impact factor: 7.045
Authors: Timothy M Farrell; Stephen P Haggerty; D Wayne Overby; Geoffrey P Kohn; William S Richardson; Robert D Fanelli Journal: Surg Endosc Date: 2009-01-06 Impact factor: 4.584
Authors: Michael F Holick; Rachael M Biancuzzo; Tai C Chen; Ellen K Klein; Azzie Young; Douglass Bibuld; Richard Reitz; Wael Salameh; Allen Ameri; Andrew D Tannenbaum Journal: J Clin Endocrinol Metab Date: 2007-12-18 Impact factor: 5.958
Authors: Maria Luger; Renate Kruschitz; Felix Langer; Gerhard Prager; Melanie Walker; Rodrig Marculescu; Friedrich Hoppichler; Karin Schindler; Bernhard Ludvik Journal: Obes Surg Date: 2015-06 Impact factor: 4.129
Authors: A Giustina; R A Adler; N Binkley; J Bollerslev; R Bouillon; B Dawson-Hughes; P R Ebeling; D Feldman; A M Formenti; M Lazaretti-Castro; C Marcocci; R Rizzoli; C T Sempos; J P Bilezikian Journal: Rev Endocr Metab Disord Date: 2020-03 Impact factor: 6.514